Rating the Risk Factors for Breast Cancer
Overview
Authors
Affiliations
Objective: To update and summarize evidence of risk factors for breast cancer.
Summary Background Data: Women who are at high risk for breast cancer have a variety of options available to them, including watchful waiting, prophylactic surgery, and chemoprevention. It is increasingly important to accurately assess a patient's risk profile to ensure that the cost/benefit ratio of the selected treatment is favorable.
Methods: Estimates of relative risk for documented risk factors were obtained from seminal papers identified in previous reviews. These estimates were updated where appropriate with data from more recent reports using large sample sizes or presenting meta-analyses of previous studies. These reports were identified from a review of the Medline database from 1992 to 2002.
Results: Risk factors that have received a great deal of publicity (hormone use, alcohol consumption, obesity, nulliparity) present a relatively modest relative risk for breast cancer (<2). Factors associated with a prior history of neoplastic disease or atypical hyperplasia and factors associated with a genetic predisposition significantly affect the risk of breast cancer, with relative risks ranging from 3 (for some cases of positive family history) to 200 (for premenopausal women positive for a BRCA mutation).
Conclusions: More precise tools, based on techniques of molecular biology such as microarray analysis, will be needed to assess individual risk for breast cancer.
Downregulation of DNAJC12 Expression Predicts Worse Survival for ER-Positive Breast Cancer Patients.
Gatti P, Mangone F, Pavanelli A, Nonogaki S, Osorio C, Capelozzi V Biomark Insights. 2025; 20:11772719251323095.
PMID: 40008192 PMC: 11851741. DOI: 10.1177/11772719251323095.
Seyyedsalehi M, Maria Kappil E, Zhang S, Zheng T, Boffetta P Med Lav. 2024; 115(6):e2024043.
PMID: 39697081 PMC: 11734636. DOI: 10.23749/mdl.v115i6.16330.
Systematic Meta-Analysis of Computer-Aided Detection of Breast Cancer Using Hyperspectral Imaging.
Leung J, Karmakar R, Mukundan A, Thongsit P, Chen M, Chang W Bioengineering (Basel). 2024; 11(11).
PMID: 39593720 PMC: 11591395. DOI: 10.3390/bioengineering11111060.
Schluter H, Bariami H, Park H Int J Environ Res Public Health. 2024; 21(8).
PMID: 39200696 PMC: 11354939. DOI: 10.3390/ijerph21081087.
Epidemiological breast cancer prediction by country: A novel machine learning approach.
El Haji H, Sbihi N, Guermah B, Souadka A, Ghogho M PLoS One. 2024; 19(8):e0308905.
PMID: 39141659 PMC: 11324133. DOI: 10.1371/journal.pone.0308905.